PATH Program


PATH advances and increases access to quality and appropriate diagnostics that improve the health outcomes of people and communities in low-resource settings.

Read more


What we do

Diagnostics are essential for advancing universal health coverage, addressing health emergencies, and promoting healthier populations. These critical tools guide clinical decision-making for patient care, curb the spread of drug resistance, support disease surveillance programs, and raise early alerts of a potential pandemic disease.

However, more than 50 percent of the world’s population has little to no access to basic diagnostics. Current diagnostics are either completely unavailable where most patients live and present for treatment or are too expensive or resource-intensive for local health systems to acquire and use.

For more than 30 years, PATH Diagnostics has collaborated with partners across the full diagnostics ecosystem to develop and commercialize appropriate, affordable, quality-assured diagnostics for conditions that disproportionately affect people in low-resource settings.

PATH’s global footprint and country capabilities accelerate improvements in delivery and access to health products.

Our focus areas

Diagnostics Leadership

  1. Neha Agarwal

    Co-Lead, Diagnostics

  2. David Boyle

    Laboratory Director and Program Co-Lead, Diagnostics

  3. Jennifer Chin

    Director of Finance & Operations, Diagnostics

  4. Gonzalo Domingo

    Scientific Director and Lead of Malaria Diagnostics

  5. Deborah Oroszlan

    Digital Engagement & Communications

  6. Roger Peck

    Senior Program Officer

  7. Helen Storey

    Program Advisor, Diagnostics

36 Articles
36 Articles
36 Articles